Biopharma

Impact of COVID-19: 4 challenges life science companies face

The COVID-19 pandemic has placed healthcare systems across the world under enormous strain, while life sciences companies scramble to do their part in addressing the disease. Medtech companies are working harder to develop and deliver more reliable diagnostic tests or meet the soaring need for ventilators and personal protective equipment. Biopharmas are racing against time […]

COVID-19: Scientific innovation will help us beat this virus

“Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” Marie Curie The Coronavirus (COVID-19) pandemic has taken the world by storm with over 380K+ cases confirmed worldwide and 16K+ deaths as of this writing.1 Although the word “pandemic” […]

COVID-19 testing: FDA guidance update

As SARS-CoV2 continues to spread, resulting in Coronavirus Disease 2019 (COVID-19) in patients, we examine FDA guidance on in vitro diagnostic testing and respirator use in healthcare settings, and highlight current trials for treatment and vaccines. The novel coronavirus, first detected in Wuhan City, Hubei Province, China, has now been detected in 50 locations worldwide, […]

Biopharma M&A activity in Q4 2019 47% higher than in Q4 2018

Understand the key drivers and trends of Q4 2019 biopharma business development activities, and get a preview of what’s in store for Q1 2020.   Total disclosed biopharma mergers and acquisitions (M&A) value increased in the fourth quarter of 2019. Disclosed deal value of the top 10 biopharma M&As increased by 47% to $24.9 billion […]

What CVS and Anthem Gained From The Centene-WellCare Deal

CVS expanded through IlliniCare Health Plan The combined carrier formed by Centene and WellCare will have a greater market share with respect to number of enrolled lives. Centene and WellCare had to divest some of their entities to go ahead with the deal. Centene signed a definitive agreement with CVS to divest its Illinois health plan […]

The Year 2019 in Japanese Health Technology Assessment

With one of the highest life expectancies among countries and an increasingly aging population, Japan is at a juncture where there are more citizens requiring healthcare services than those contributing to the expenditure. The pressure to bring down healthcare spending is enormous and the need for a sustainable healthcare system is more crucial than ever. […]